Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?

Peritoneal Dialysis International

Volumn 26, Issue 3, 2006, Pages 341-348

  Cueto Manzano, Alfonso M ^a,d   Rojas Campos, Enrique ^a   Martiínez Ramírez, Héctor R ^a   Valera González, Isela ^a   Medina, Miguel ^a   Monteón, Francisco ^a   Ruiz, Norma ^b   Becerra, Mauricio ^b   Palomeque, Miguel A ^c   Cortés Sanabria, Laura ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b HGZ 46   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d IMSS ^*  (Mexico)

Author keywords

C reactive protein; CCPD; High peritoneal transport rate; Interleukin 6; NIPD; Tumor necrosis factor alpha

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSATE; DIALYSATE LEVEL; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MALE; MEMBRANE PERMEABILITY; NEPHELOMETRY; PERITONEAL DIALYSIS; PERITONEUM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 33748429892     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600311     Document Type: Article

References (26)

1. Bergstrom J, Lindholm B. Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis 1998; 32:834-41.
2. Stenvinkel P, Chung SH, Heimbürger O, Lindholm B. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit Dial Int 2001; 21(Suppl 3):S157-62.
3. Pecoits-Filho R, Araújo MRT, Lindholm B, Stenvinkel P, Abensur H, Romão, JE, et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17:1480-6.
4. Cueto-Manzano AM, Salazar M, Valera-Gonzalez I, Rojas-Campos E, Martinez-Ramirez HR, Cortes-Sanabria L, et al. Association between the peritoneal transport rate and systemic inflammation marker in continuous ambulatory peritoneal dialysis [Abstract]. J Am Soc Nephrol 2002; 13: 201A.
5. Cueto-Manzano AM, Correa-Rotter R. Is high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int 2000; 57:314-20.
6. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Pagé D, forthe CANUSA Peritoneal Dialysis Study Group. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998; 9: 1285-92.
7. Witowski J, Jörres A, Coles GA, Williams JD, TopLey N. Superinduction of IL-6 synthesis in human peritoneal mesothelial cells related to the induction and stabilization of IL-6 mRNA. Kidney Int 1996; 50:1212-23.
8. Serre AF, Marie C, Beaujon G, Betail G, Cavaillon JM, Deteix P. Variations of cytokine levels and production in CAPD patients. Int J Artif Organs 1997; 20:614-21.
9. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severechronic heart failure. N Engl J Med 1990; 323:236-41.
10. Chung SH, Heimburger O, Stenvinkel P, Wang T, Lindholm B. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int 2003; 23:174-83.
11. Oreopoulos DG, Rao PS. Assessing peritoneal ultrafiltration, solute transport, and volume status. In: Daugirdas JT, Blake PG, Ing TS, eds. Handbook of Dialysis. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001: 361-72.
12. Cueto-Manzano AM, Díaz-Alvarenga A, Correa-Rotter R. Analysis of the peritoneal equilibration test in Mexico and factors influencing the peritoneal transport rate. Perit Dial Int 1999; 19:45-50.
13. The National Kidney Foundation. K/DOQI Guidelines. Available at URL: http://www.kidney.org (Accessed March 2005)
14. Fusshoeller A, Plail M, Grabensee B, Plum J. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Nephrol Dial Transplant 2004; 19:2101-6.
15. Wang T, Heimburger O, Cheng HH, Bergstrom J, Lindholm B. Does a high peritoneal transport rate reflect a state of chronic inflammation? Perit Dial Int 1999; 19:17-22.
16. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265:621-36.
17. Weber J, Yang JC, Topahan SL, Parkinson DR, Schwartzentruber DS, Ettinghausen SE, et al. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 1993; 11:499-506.
18. Stegant CE, Bargman JM. What's new in peritoneal dialysis: biocompatibility and continuous flow peritoneal dialysis. Curr Opin Nephrol Hypertens 2002; 11:597-601.
19. Cueto-Manzano AM, Correa-Rotter R. Biocompatibilidad en diálisis peritoneal. Nefrología 1996; 16:111-18.
20. Duwe AK, Vas SI, Weatherhead JW. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981; 33:130-5.
21. Wollert KC, Drexler H. The role of interleukin-6 in the failing heart. Heart Fail Rev 2001; 6:95-103.
22. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 2004; 95:1140-53.
23. Libetta C, Rampino T, Dal Canton A. Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients. Am J Kidney Dis 2001; 38:286-95.
24. Stenvinkel P, Ketteler M, Johnson RJ. IL-10, IL-6, and TNFα: central factors in the altered cytokine network of uremia-the good, the bad and the ugly. Kidney Int 2005; 67:1216-33.
25. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, et al. Balance between IL-1β, TNFα, and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol 1995; 154: 882-92.
26. Wanner C, Zimmermann J, Schwedler S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 2002; 80:S99-102.